Home › Heart Failure › New York › Poughkeepsie
Heart Failure clinical trials in Poughkeepsie, NY
6 studies for Heart Failure are looking for participants at sites in and around Poughkeepsie (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecruitingObservational study
- Poughkeepsie, Poughkeepsie
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RecruitingPhase 3
- Hudson Valley Cardiovascular Practice, Poughkeepsie
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- Hudson Valley Cardiovascular Practice PC, Poughkeepsie
Assessment of CCM in HF With Higher Ejection Fraction
Recruiting
- Nuvance Health - Heart & Vascular Institute/Hudson Valley Cardiovascular Practice, PC, Poughkeepsie
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Recruiting
- Nuvance Health, Poughkeepsie
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Vassar Brothers- Hudson Valley Cardiovascular Practice, Poughkeepsie
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA46 studies
- Dallas, TX42 studies
- Houston, TX35 studies
- Cleveland, OH31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Chicago, IL28 studies
- Durham, NC25 studies
- Kansas City, MO25 studies
- St. Louis, MO24 studies
- Indianapolis, IN24 studies
Other studies in Poughkeepsie
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.